Forte Biosciences, Inc.
FBRX
$11.16
-$0.10-0.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 333.28% | 50.62% | 57.21% | -64.57% | -19.48% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -1.78% | 3.39% | 155.06% | 25.27% | 366.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 87.86% | 92.70% | 103.64% | 191.49% | 142.64% |
| Total Current Assets | 318.56% | 49.70% | 60.06% | -62.49% | -16.38% |
|
|
|||||
| Total Current Assets | 318.56% | 49.70% | 60.06% | -62.49% | -16.38% |
| Net Property, Plant & Equipment | 14.58% | 17.92% | -29.36% | -12.24% | 220.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -78.97% | -56.97% | -74.63% | -71.72% | -33.42% |
| Total Assets | 313.31% | 48.23% | 57.93% | -62.52% | -16.37% |
|
|
|||||
| Total Accounts Payable | 0.49% | 198.10% | 242.63% | -3.64% | 75.48% |
| Total Accrued Expenses | 0.70% | 143.41% | 87.42% | 61.60% | 16.64% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 0.58% | 171.07% | 147.71% | 14.84% | 44.71% |
|
|
|||||
| Total Current Liabilities | 0.58% | 171.07% | 147.71% | 14.84% | 44.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 0.58% | 171.07% | 147.71% | 14.84% | 44.71% |
|
|
|||||
| Common Stock & APIC | 79.85% | 34.57% | 34.22% | 2.06% | 21.82% |
| Retained Earnings | -30.66% | -34.71% | -29.93% | -30.36% | -34.82% |
| Treasury Stock & Other | -- | -- | 175.00% | 120.00% | -800.00% |
| Total Common Equity | 481.41% | 33.96% | 48.61% | -76.82% | -31.84% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 481.41% | 33.96% | 48.61% | -76.82% | -31.84% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 481.41% | 33.96% | 48.61% | -76.82% | -31.84% |
|
|
|||||